Effects of cognitive and motor rehabilitation in non-convulsive status epilepticus: A case report

2018 ◽  
Vol 54 ◽  
pp. 137-139
Author(s):  
Francesco Corallo ◽  
Viviana Lo Buono ◽  
Marcella Di Cara ◽  
Simona De Salvo ◽  
Giuliana Vermiglio ◽  
...  
2012 ◽  
Vol 114 (10) ◽  
pp. 1371-1373 ◽  
Author(s):  
Debora Mazzei ◽  
Jennifer Accardo ◽  
Alessandra Ferrari ◽  
Alberto Primavera

2020 ◽  
Vol 14 ◽  
pp. 100371
Author(s):  
Barbara Ladisich ◽  
Ferdinand Otto ◽  
Lukas Machegger ◽  
Waltraud Kleindienst ◽  
Eugen Trinka ◽  
...  

Author(s):  
Nhat Nguyen Tuan Huynh ◽  
Akutsu Hiroyoshi ◽  
Noguchi Shozo ◽  
Tsunoda Takashi ◽  
Tsurushima Hideo ◽  
...  

2014 ◽  
Vol 19 (4) ◽  
pp. 317-324
Author(s):  
Chasity M. Shelton ◽  
Elizabeth L. Alford ◽  
Stephanie Storgion ◽  
James Wheless ◽  
Stephanie J. Phelps

We describe the use of topiramate in a healthy 12-year-old (88-kg) male who developed refractory generalized convulsive status epilepticus. Seizures persisted despite aggressive use of benzodiazepines (intravenous lorazepam; oral clorazepate), barbiturates (i.e., phenobarbital, pentobarbital), and hydantoins. The child's seizures were controlled with nasogastrically administered topiramate in doses up to 500 mg twice daily (11.4 mg/kg/day). The patient did not display any clinical or laboratory signs of metabolic acidosis while receiving topiramate. Topiramate should be considered as a treatment option in refractory status epilepticus.


Sign in / Sign up

Export Citation Format

Share Document